Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Phillips-Medisize Holdings A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark XBRLDenmarkIFRS Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.9% 1.9% 1.9% 1.9% 1.9% 1.9% 1.9% 1.9%   Bankruptcy risk   5.1% 3.4% 3.3% 0.0% 1.5% 0.9% 3.7% 3.6%   Credit score (0-100)   45 55 54 0 75 88 52 52   Credit rating   BBB BBB BBB N/A A A BBB BBB   Credit limit (mDKK)   -0.0 -0.0 -0.0 0.0 0.3 16.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 391 497 497 497   Gross profit   0.0 0.0 0.0 0.0 105 186 0.0 0.0   EBITDA   0.0 0.0 0.0 0.0 47.6 97.8 0.0 0.0   EBIT   0.0 0.0 0.0 0.0 47.6 97.8 0.0 0.0   Pre-tax profit (PTP)   -15.3 -10.6 8.8 0.0 28.6 84.6 0.0 0.0   Net earnings   -15.3 -10.6 8.8 0.0 15.0 58.9 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 0.0 0.0 28.6 84.6 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 45.8 45.5 0.0 0.0   Shareholders equity total   -4.9 -15.5 -6.7 0.0 -5.1 54.0 53.5 53.5   Interest-bearing liabilities   0.0 0.0 0.0 0.0 292 278 0.0 0.0   Balance sheet total (assets)   191 196 191 0.0 414 446 53.5 53.5   Net Debt   0.0 -0.3 4.0 0.0 202 101 -13.1 -13.1     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 391 497 497 497   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 27.2% 0.0% 0.0%   Gross profit   0.0 0.0 0.0 0.0 105 186 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 0.0% 0.0% 78.3% -100.0% 0.0%   Employees   0 0 0 0 227 233 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 2.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   191 196 191 0 414 446 54 54   Balance sheet change%   3.0% 2.6% -2.3% -100.0% 0.0% 7.7% -88.0% 0.0%   Added value   0.0 0.0 0.0 0.0 47.6 97.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 12.2% 19.7% 0.0% 0.0%   Investments   0 0 0 0 103 -17 -46 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0   EBIT trend   0.0 0.0 0.0 0.0 1.0 2.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 12.2% 19.7% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 12.2% 19.7% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 0.0% 0.0% 45.5% 52.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 3.8% 11.9% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 3.8% 11.9% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 7.3% 17.0% 0.0% 0.0%   ROA %   0.0% 0.0% 0.0% 0.0% 12.2% 25.2% 0.0% 0.0%   ROI %   0.0% 0.0% 0.0% 0.0% 17.4% 34.7% 0.0% 0.0%   ROE %   -293.3% 103.9% -79.1% 0.0% 3.6% 25.2% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 0.0% 0.0% -1.2% 12.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 107.0% 78.4% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 84.1% 43.0% -2.6% -2.6%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% 424.9% 103.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% -5,706.9% 514.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 15.5% 8.6% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 0.0 1.4 1.6 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 1.5 1.8 0.0 0.0   Cash and cash equivalent   0.0 0.3 -4.0 0.0 89.5 176.2 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 79.5% 72.4% 2.6% 2.6%   Net working capital   6.0 10.9 6.3 0.0 108.4 159.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 27.7% 32.0% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 2 2 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0